{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:34:30Z","timestamp":1784306070303,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jacl.2018.05.003","type":"journal-article","created":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T05:29:59Z","timestamp":1527312599000},"page":"1290-1297.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Association between high-density lipoprotein subfractions and low-grade inflammation, insulin resistance, and metabolic syndrome components: The ELSA-Brasil study"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1010-2428","authenticated-orcid":false,"given":"Giuliano","family":"Generoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela M.","family":"Bensenor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul D.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itamar S.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra C.","family":"Goulart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnaji R.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Blaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo A.","family":"Lotufo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio Sommer","family":"Bittencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2018.05.003_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbacli.2015.01.005","article-title":"High density lipoproteins: measurement techniques and potential biomarkers of cardiovascular risk","volume":"3","author":"Hafiane","year":"2015","journal-title":"BBA Clin"},{"issue":"6","key":"10.1016\/j.jacl.2018.05.003_bib2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/01.ATV.8.6.737","article-title":"High density lipoprotein cholesterol and mortality. The Framingham heart study","volume":"8","author":"Wilson","year":"1988","journal-title":"Arterioscler"},{"issue":"22","key":"10.1016\/j.jacl.2018.05.003_bib3","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.jacl.2018.05.003_bib4","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.jacl.2018.05.003_bib5","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.2011.1649","article-title":"Effects of the CETP Inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial","volume":"306","author":"Nicholls","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2018.05.003_bib6","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","volume":"377","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jacl.2018.05.003_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","year":"2014","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jacl.2018.05.003_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/eurheartj\/eht571","article-title":"Mendelian randomization of blood lipids for coronary heart disease","volume":"36","author":"Holmes","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2018.05.003_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/943162","article-title":"A Comprehensive review on metabolic syndrome","volume":"2014","author":"Kaur","year":"2014","journal-title":"Cardiol Res Pract"},{"issue":"21","key":"10.1016\/j.jacl.2018.05.003_bib10","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men","volume":"288","author":"Lakka","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jacl.2018.05.003_bib11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/diacare.24.4.683","article-title":"Cardiovascular morbidity and mortality associated with the metabolic syndrome","volume":"24","author":"Isomaa","year":"2001","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.jacl.2018.05.003_bib12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms","volume":"8","author":"Navab","year":"2011","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"10.1016\/j.jacl.2018.05.003_bib13","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/01.ATV.18.9.1450","article-title":"Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells","volume":"18","author":"Ashby","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.jacl.2018.05.003_bib14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cll.2006.07.004","article-title":"Cholesterol profile measurement by vertical auto profile method","volume":"26","author":"Kulkarni","year":"2006","journal-title":"Clin Lab Med"},{"issue":"1","key":"10.1016\/j.jacl.2018.05.003_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/eurheartj\/ehu264","article-title":"HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the lipoprotein investigators collaborative","volume":"36","author":"Martin","year":"2015","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacl.2018.05.003_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/2047487314543890","article-title":"Association of high-density lipoprotein subclasses and incident coronary heart disease: The Jackson heart and Framingham offspring cohort studies","volume":"23","author":"Joshi","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"10.1016\/j.jacl.2018.05.003_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/01.CIR.84.1.129","article-title":"HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men","volume":"84","author":"Salonen","year":"1991","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacl.2018.05.003_bib18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0002-9149(92)91186-8","article-title":"Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease","volume":"70","author":"Drexel","year":"1992","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.jacl.2018.05.003_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/aje\/kwr294","article-title":"Brazilian longitudinal study of adult health (ELSA-Brasil): objectives and design","volume":"175","author":"Aquino","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.jacl.2018.05.003_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/ije\/dyu027","article-title":"Cohort profile: longitudinal study of adult health (ELSA-Brasil)","volume":"44","author":"Schmidt","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jacl.2018.05.003_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1590\/S0034-8910.2013047003807","article-title":"Logistica de coleta e transporte de material biologico e organizacao do laboratorio central no ELSA-Brasil","volume":"47","author":"Fedeli","year":"2013","journal-title":"Rev Sa\u00fade P\u00fablica"},{"key":"10.1016\/j.jacl.2018.05.003_bib22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/S0034-8910.2013047003822","article-title":"Delineamento e implementacao do biobanco do ELSA-Brasil: estudo prospectivo na populacao brasileira","volume":"47","author":"Pereira","year":"2013","journal-title":"Rev Sa\u00fade P\u00fablica"},{"issue":"7","key":"10.1016\/j.jacl.2018.05.003_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and\u202f?-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.jacl.2018.05.003_bib24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome-a new world-wide definition. A consensus statement from the international diabetes federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet Med"},{"issue":"9","key":"10.1016\/j.jacl.2018.05.003_bib25","doi-asserted-by":"crossref","first-page":"e0163044","DOI":"10.1371\/journal.pone.0163044","article-title":"Timing and type of alcohol consumption and the metabolic syndrome - ELSA-Brasil","volume":"11","author":"Vieira","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jacl.2018.05.003_bib26","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/01.ATV.12.3.332","article-title":"Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women","volume":"12","author":"Williams","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.jacl.2018.05.003_bib27","article-title":"High Density Lipoproteins","volume":"Vol. 224","year":"2015"},{"key":"10.1016\/j.jacl.2018.05.003_bib28","series-title":"Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine","first-page":"980","year":"2015"},{"issue":"6","key":"10.1016\/j.jacl.2018.05.003_bib29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM199108083250601","article-title":"A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction","volume":"325","author":"Stampfer","year":"1991","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jacl.2018.05.003_bib30","doi-asserted-by":"crossref","first-page":"e91565","DOI":"10.1371\/journal.pone.0091565","article-title":"Effects of lipid-lowering drugs on high-density lipoprotein subclasses in healthy men\u2014a randomized trial","volume":"9","author":"Berthold","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jacl.2018.05.003_bib31","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.atherosclerosis.2016.06.019","article-title":"Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial","volume":"251","author":"Albers","year":"2016","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.jacl.2018.05.003_bib32","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jacl.2012.03.001","article-title":"High-density lipoprotein subclasses and their relationship to cardiovascular disease","volume":"6","author":"Superko","year":"2012","journal-title":"J Clin Lipidol"},{"issue":"2","key":"10.1016\/j.jacl.2018.05.003_bib33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.atherosclerosis.2007.12.020","article-title":"Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol","volume":"200","author":"Rizzo","year":"2008","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.jacl.2018.05.003_bib34","doi-asserted-by":"crossref","first-page":"e000902","DOI":"10.1161\/JAHA.114.000902","article-title":"HDL-3 is a superior predictor of carotid artery disease in a case-control cohort of 1725 participants","volume":"3","author":"Kim","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.jacl.2018.05.003_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11745-008-3251-9","article-title":"Alterations in the high density lipoprotein phenotype and HDL-Associated enzymes in subjects with metabolic syndrome","volume":"44","author":"Lagos","year":"2009","journal-title":"Lipids"},{"issue":"6","key":"10.1016\/j.jacl.2018.05.003_bib36","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/0026-0495(95)90193-0","article-title":"Change in skeletal muscle lipoprotein lipase activity in response to insulin\/glucose in non-insulin-dependent diabetes mellitus","volume":"44","author":"Yost","year":"1995","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.jacl.2018.05.003_bib37","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0009-9120(03)00078-X","article-title":"Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity","volume":"36","author":"Rashid","year":"2003","journal-title":"Clin Biochem"},{"issue":"7","key":"10.1016\/j.jacl.2018.05.003_bib38","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1194\/jlr.M003525","article-title":"Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys","volume":"51","author":"Tang","year":"2010","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.jacl.2018.05.003_bib39","doi-asserted-by":"crossref","first-page":"e22142","DOI":"10.1371\/journal.pone.0022142","article-title":"Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function","volume":"6","author":"Patel","year":"2011","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.jacl.2018.05.003_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0021-9150(93)90177-V","article-title":"Accelerated cholesteryl ester transfer in noninsulin-dependent diabetes mellitus","volume":"104","author":"Bagdade","year":"1993","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.jacl.2018.05.003_bib41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2337\/diabetes.53.3.513","article-title":"Transcriptional control of apolipoprotein A-I gene expression in diabetes","volume":"53","author":"Mooradian","year":"2004","journal-title":"Diabetes"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418302150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418302150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T20:08:32Z","timestamp":1539115712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287418302150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1933287418302150"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2018.05.003","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between high-density lipoprotein subfractions and low-grade inflammation, insulin resistance, and metabolic syndrome components: The ELSA-Brasil study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2018.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}